MARKET

CDXC

CDXC

Chromadex Corp
NASDAQ
1.970
-0.140
-6.64%
After Hours: 2.000 +0.03 +1.52% 16:01 01/30 EST
OPEN
2.110
PREV CLOSE
2.110
HIGH
2.190
LOW
1.970
VOLUME
234.27K
TURNOVER
0
52 WEEK HIGH
3.160
52 WEEK LOW
1.150
MARKET CAP
146.70M
P/E (TTM)
-6.5820
1D
5D
1M
3M
1Y
5Y
ChromaDex Shares Promising Findings From First-Of-Its Kind Clinical Study To Demonstrate Oral Nicotinamide Riboside Supplementation Increases Muscle Mitochondrial Biogenesis
Benzinga · 01/17 13:29
BRIEF-ChromaDex Names Brianna Gerber As Chief Financial Officer
Reuters · 01/05 14:28
ChromaDex appoints Brianna Gerber as CFO
Seeking Alpha · 01/05 14:08
ChromaDex Names Brianna Gerber As CFO
ChromaDex Names Brianna Gerber As CFO
MT Newswires · 01/05 12:06
ChromaDex Shares Findings From Clinical Study Demonstrating Oral Supplementation With Nicotinamide Riboside Increased Nicotinamide Adenine Dinucleotide Levels In The Brain And Positively Impacted Neurodegenerative Biomarkers
Benzinga · 12/27/2022 13:34
Here's Why ChromaDex (CDXC) is Poised for a Turnaround After Losing 7.5% in 4 Weeks
ChromaDex (CDXC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend ...
Zacks · 12/16/2022 14:35
BRIEF-Chromadex Reports FDA's Conclusion That Nicotinamide Mononucleotide May Not Be Sold Or Marketed As Dietary Supplement In U.S.
Reuters · 11/11/2022 14:13
ChromaDex Reports FDA's Conclusion That Nicotinamide Mononucleotide; May Not Be Sold Or Marketed As A Dietary Supplement In The United States
Benzinga · 11/11/2022 13:13
More
About CDXC
ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Webull offers kinds of Chromadex Corp stock information, including NASDAQ:CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDXC stock methods without spending real money on the virtual paper trading platform.